CDKN2A and cancer: To test this hypothesis, small interfering RNA (siRNA) was firstly applied to knockdown the expression of RBX1 to disassemble the CRL complex, and p14/ARF protein level was analyzed by immunoblotting subsequently in several human cancer cell lines.